Argentine health authorities Tuesday announced the arrival into the country of around 100,000 doses of Pfizer COVID-19 vaccines, which will be used as the second shots of Sputnik V.
Peru's President Pedro Castillo has announced a plant to manufacture the Russian-developed Sputnik V COVID-19 locally will be set up in the country, for which the government has allocated US $ 705 million worth of funding.
Chilean health authorities have approved the emergency use of the Sinovac Biotech (CoronaVac) coronavirus vaccine on children aged six years or older, it was announced Monday.
Pan American Health Organization Director Carissa F. Etienne warned that 75% of the population in Latin America and the Caribbean has yet to be fully vaccinated against COVID-19 and reported that PAHO is accelerating its drive to expand vaccine access throughout the region.
The former Co-Chairs of the Independent Panel on Pandemic Preparedness and Response (IPPPR), Ellen Johnson Sirleaf, former President of Liberia, and Helen Clark, former Prime Minister of New Zealand, have expressed their deep concern at the slow pace of redistribution of COVID-19 vaccines from high income to low-income countries.
Brazilian President Jair Bolsonaro Monday upped the ante in his feud with the country's Federal Supreme Court (STF) saying the body was preparing the ground to arrest him, under charges of being a threat to democracy.
A high ranking Israeli health official has admitted the country is having second thoughts about what it means to be fully vaccinated against COVID-19 as cases mount nationwide and the third dose of vaccine is being made available for whoever wants to take it.
The City Hall of Rio de Janeiro Friday announced that effective September 1, a COVID-19 vaccination passport will be required for customers to be allowed to enter cinemas, theatres, museums, stadiums, amusement parks and gyms.
Brazilian carrier Gol Linhas Aéreas Thursday announced that starting in November, it will require all its employees to have taken a full COVID-19 vaccine treatment.
The multinational Pfizer-BioNTech consortium has reached a deal with Brazilian laboratories Eurofarma to produce its famous COVID-19 vaccine in the South American country, it was announced Thursday.